|4May 28, 9:22 PM ET

Behar Gregory 4

4 · Aimmune Therapeutics, Inc. · Filed May 28, 2019

Insider Transaction Report

Form 4
Period: 2019-05-23
Transactions
  • Award

    Common Stock, $0.0001 par value

    2019-05-23+6,44210,192 total
  • Award

    Stock Option (right to buy)

    2019-05-23+11,43211,432 total
    Exercise: $19.90Exp: 2029-05-23Common Stock (11,432 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
  • [F2]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION